The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases
- DOI
- 10.1016/j.pharmthera.2017.08.015
- Published
- 2018-02
- Container
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.pharmthera.2017.08.015,
title = {The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases},
author = {Luc Rochette and Alexandre Meloux and Eve Rigal and Marianne Zeller and Yves Cottin and Catherine Vergely},
year = {2018},
journal = {Pharmacology \& Therapeutics},
doi = {10.1016/j.pharmthera.2017.08.015},
url = {https://doi.org/10.1016/j.pharmthera.2017.08.015}
}RIS
TY - JOUR TI - The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases AU - Luc Rochette AU - Alexandre Meloux AU - Eve Rigal AU - Marianne Zeller AU - Yves Cottin AU - Catherine Vergely PY - 2018 JO - Pharmacology & Therapeutics DO - 10.1016/j.pharmthera.2017.08.015 UR - https://doi.org/10.1016/j.pharmthera.2017.08.015 ER -
APA
Rochette, L., Meloux, A., Rigal, E., Zeller, M., Cottin, Y., & Vergely, C. (2018). The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases. Pharmacology & Therapeutics. https://doi.org/10.1016/j.pharmthera.2017.08.015
Source records
- crossref · retrieved 2026-09-26T21:01:17.232Z